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Plastic bronchitis (PB) is a disease characterized by the formation of the endobronchial casts that fully or partially obstruct the bronchial lumen [1]. It is a rare clinical entity 
of unknown etiology. It is characterized by the accumulation of 
fibrinous mucous plugs as a three-dimensional architecture in the 
bronchial tree. It often partially or completely blocks the airway 
and leads to respiratory distress [2]. Although the etiopathology 
of PB is not well understood, pediatric patients with underlying 
cardiac diseases are prone for developing bronchial casts, 
particularly after surgical intervention with direct systemic blood 
flow into the pulmonary circulation [3]. These endobronchial 
casts are more adhesive than mucous plugs and attain the shape 
of the tracheobronchial tree [4]. The clinical presentations of the 
patients are cough, dyspnea, fever, and wheezing which are often 
confused with inhaled foreign body in the bronchus. Medical 
treatment for PB includes inhaled or systemic corticosteroids, 
aerosolized acetylcysteine, aerosolized heparin, and tissue 
plasminogen which might be used to liquefy and subsequently 
remove the casts from the tracheobronchial airway. If this fails, 
bronchoscopic intervention is required for better clearance of the 
airway.
METHODOLOGY
For searching the published research article, we conducted 
an electronic survey of the SCOPUS, Medline, and PubMed 
databases. The search term in the database included PB in 
the pediatric patient. The abstracts of the published article 
were identified by this search method and other articles were 
identified manually from citations. This manuscript reviews 
the etiopathology, epidemiology, clinical presentations, and 
diagnosis and treatment of PB in pediatric patients. This review 
article presents a baseline from where further prospective trials 
for PB could be designed and helps as a spur for further research 
in this rarely encountered clinical entity.
EPIDEMIOLOGY
The prevalence of PB is unknown [5]; however, in the case of 
Fontan, it is reported between 4% and 14% [6]. Its mortality 
rate was described among 5–60% cases [7]. PB can affect any 
age group but is more common among children [8]. Males and 
females are usually equally affected but Kumar et al., 2018 
reported female predominance [9]. The true prevalence of PB is 
still unknown which might be due to its unusual nature. Until date, 
there are around 500 cases documented in medical literature [7]. 
The first known case of PB was described in second century BC 
by Galen, a Greco-Roman physician, who documented patient 
that expectorated soft and viscous casts that were thought to 
be veins and arteries. Fifteen hundred years later, Morgagni 
identified the expectorated material as mucus casts arising from 
the endobronchial airway rather than pulmonary veins [10]. 
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To date, the exact incidence is unknown and it is probably an 
underdiagnosed disease [11]. One study documented that overall 
mortality rate of PB is 16% and it is up to 29% in patients with 
cardiac defects. More life-threatening situations are seen in PB 
with cardiac defects [12].
ETIOPATHOLOGY
PB is an uncommon, potential fatal clinical condition with 
extensive inspissated mucofibrinous bronchial casts mimicking 
the three-dimensional architecture of the tracheobronchial 
airway [8]. Its consistency is sticky and often difficult to remove 
by bronchoscopic procedure that differentiates this condition 
from ordinary mucus plug in the tracheobronchial airway [13]. 
It is characterized by the production of endobronchial casts 
of protease content, which act as a foreign body along the 
bronchial tree [14]. It is seen as a complication of respiratory 
diseases, lymphatic abnormalities, infective cause, and surgery, 
particularly for congenital heart diseases (CHDs), especially 
Fontan procedure [1].
PB is a potential fatal pathology which is often seen in patients 
with a history of Fontan palliative cardiovascular surgery. Fontan 
surgical technique was designed for pediatric patients having 
CHDs with single ventricle heart. It establishes passive blood 
flow through the lungs by diverting both the superior and inferior 
vena cava circulation directly to the pulmonary arteries and 
leads to alteration of the pulmonary vascular dynamics. As this 
Fontan procedure is becoming safer, so the survival rate of the 
patient is improving with lesser chance of formation of PB in 
the tracheobronchial tree. PB is seen more frequently, where the 
formation of casts occludes the bronchial airway without causing 
stenosis. There is no evidence of reduced bronchial lumen despite 
several airway cleaning procedures.
Sometimes, Fontan procedure defect improves the pulmonary 
symptoms but at the same time, there is an alteration of the 
systemic circulation. Occasionally, the procedure must be 
reverted, to minimize the fatality of the PB, which is usually a 
complex situation due to the cardiovascular implications [15]. The 
raised venous pressure along with dysfunction, loss of integrity in 
the endobronchial mucosa and increase in the lymphatic vessels 
pressure of the thorax is usually associated with broncho-lymphatic 
fistulas with production of the casts in the bronchial tree [16]. 
Certain conditions associated with PB are cyanotic CHDs, 
bronchial asthma, lymphatic disorders, pulmonary infections, 
sickle cell anemia, and lymphoma. Angelos et al. studied pediatric 
PB patients and revealed that 40% of patients had underlying 
cardiac defects, 31% had asthma or allergic disorders, and 29% 
had other disorders [12].
The Seear classification of PB is divided into two categories and 
is useful for the diagnosis and appropriate adjunctive treatment. 
Type-I PB is described as hypercellular and is usually associated 
with inflammatory mediators such as fibrin, neutrophils, and 
eosinophils. Inflammatory conditions of lungs such as asthma, 
acute chest syndrome, and allergic bronchopulmonary aspergillosis 
are included in Type-I. Type-II PB is described as a transudative, 
mucoid precipitate which increases central venous pressure as 
in CHDs and lymphatic leakage [17]. Type-II or acellular casts 
primarily consist of mucin with no acute inflammatory cells and 
sometimes a few mononuclear cellular components. These casts 
are usually seen in children with underlying cardiac problems.
Recently, there is another classification of PB on the 
etiological basis. There are four etiological groups associated with 
this classification. CHD is associated with acellular mucinous 
casts. Asthma and atopic disorders are associated with abundant 
eosinophils, Charcot–Leyden crystals, neutrophils, and fibrin. 
Lymphatic diseases have chylous casts and sometimes consist of 
fibrin. Sickle cell anemia is associated with casts which consist of 
fibrinous material and pigmented histiocytes in the surrounding 
fluid [15]. Once endobronchial casts are expectorated, it is 
cohesive and rubbery in consistency than ordinary mucus plug. 
The cast possesses varying proportion of mucin, fibrin, and 
cellular materials. The expectorate casts are often mistaken with 
different food materials such as noodles, chicken, and meat.
CLINICAL PRESENTATION
Patients usually present with mild symptoms of breathing 
difficulty, cough, and life-threatening conditions like death. 
The typical clinical presentations of the patient are dyspnea, 
wheezing, coughing, respiratory distress, and occasionally chest 
pain or fever [18]. Wheezing is the commonest clinical finding. It 
is an unusual disease in pediatric age group where cough persists 
after adequate and prolonged treatment. This failed treatment 
gives a high suspect of this rare disease. The hallmark for PB 
is finding casts in bronchial tree during bronchoscopy. Imaging 
shows atelectasis and infiltrates on affected side of the lungs and 
often hyperinflation in the contralateral side [19].
The expectorated bronchial cast varies in duration and 
frequency and sometimes might be complicated with hemoptysis. 
Some patients are unable to expectorate the bronchial cast 
spontaneously which might delay or hide the diagnosis. The 
clinician should intervene early if clinical presentations of airway 
obstruction are noticed. In severe cases of PB, substantial cast 
obstruction might lead to fatal outcome such as cardiorespiratory 
collapse. PB is considered as a differential diagnosis when the 
patient presents with clinical presentations such as severe airway 
obstruction, weak breath sounds, persistent, and respiratory 
distress which cannot be explained by acute respiratory distress 
syndrome or acute lung injury and the presence of cord-like 
material in expectorant.
However, the clinical presentations of PB are nonspecific and 
usually inconsistent with chest X-ray findings. The classification 
and diagnosis of PB are mainly done on the basis of bronchoscopy 
and histopathological biopsy of expelled cast. It is an uncommon 
disease and must be taken into account with recurrent atelectasis 
and in cases of suspected endobronchial foreign body. Patients 
with underlying heart diseases are at a greater risk of death 
whereas with inflammatory process show less severe clinical 
presentations.
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DIAGNOSIS
The radiological study reveals the site of the impaction of bronchial 
cast and atelectasis or infiltrates. Chest X-ray is often done at initial 
routine investigation for finding the PB at bronchial airway (Fig. 1). 
Hyperinflations of lungs are often evident in the contralateral 
side of lungs. Computed tomography (CT) scan usually shows 
impacted casts in the bronchial airways. CT scan with axial view 
of the chest demonstrates the presence of atelectasis with blockage 
of endobronchial airway in the affected side. The radiological 
assessment reveals the site for bronchial casts, showing atelectasis, 
or infiltration, usually in lower lobes. Hyperinflation is usually 
located on the contralateral side. CT scan allows for visualization 
of the casts within the tracheobronchial airway.
The diagnosis is usually confirmed by rigid bronchoscopy 
which demonstrates the obstruction of the endobronchial casts. 
Endobronchial casts often look whitish-yellowish color and 
are too thick in consistency to be suctioned out from bronchus. 
Few patients expectorate the casts spontaneously which is often 
mistaken for food materials such as noodles or chicken meat [20]. 
Some casts appear blackish and soft inconsistency. The lung 
biopsy specimen usually demonstrates mucin cell hyperplasia 
without any other pathological significance. PB can be seen at all 
levels of the tracheobronchial tree but is more commonly found 
in the lower lobe.
Mucoid impaction in the tracheobronchial airway differs 
from PB in several ways such as mucoid plugs tend to be in 
the large segmental bronchi of the upper lobe of the lungs, 
and they are firmly adherent to the bronchial wall and retained 
rather than being expectorated. Mucoid plug impaction has a 
strong correlation with bronchial asthma [21]. Imaging showing 
atelectasis is a differential diagnosis for foreign body aspiration. 
The exact pathophysiology for PB is not fully understood, but 
raised pulmonary venous pressure leading to abnormal response 
of respiratory epithelium which causes excess mucus production 
might be the cause for PB [22]. As lymphatic leakage is 
another proposed etiology for endobronchial cast formation, so 
lymphangiography is considered as a diagnostic tool for patients 
of Type II PB.
TREATMENT
The treatment of PB is often challenging to the clinician. There 
has been no intervention proven effective for treatment of PB 
regardless of the etiology and physical properties of endobronchial 
casts. Treatment includes removal of casts and addressing the 
underlying hypersecretory process. Immediate treatment of PB 
ranges from medical treatment with corticosteroids, different 
inhaled lytic agents to bronchoscopy, and potentially other surgical 
procedures. Corticosteroids are often useful in inflammatory casts 
(Type-I). Bronchoscopic removal of endobronchial casts has been 
routinely practiced in most of the cases. PB is usually removed by 
bronchial lavage by bronchoscopic approach which is considered as 
the standard treatment [23]. The casts found in bronchus are often 
described as “pudding like” or with toothpaste appearance. Many of 
the casts are too thick to be suctioned out through a bronchoscope 
or too friable to be grasped and removed by forceps (Fig. 2). Few 
patients are able to expectorate spontaneously as large casts.
A mucolytic agent such as dornase alfa might be used to 
liquefy the dense and viscous PB [24]. At present, 7% hypertonic 
saline solution which attracts water into thick and viscous 
mucus secretions has good outcome [25]. Chest physiotherapy, 
acetylcysteine, systemic and inhaled corticosteroids, and DNAase 
have been used in PB. One recent document showed aerosolized 
urokinase might be used for treating bronchial casts [26]. Rigid 
bronchoscopy showed tenacious secretions in the endobronchial 
airway.
The use of bronchoscopic instruments for the removal of 
bronchial cast has been documented by Raghuram et al. in 
1997 [27]. Rigid bronchoscopy has dual role in both diagnosing the 
casts and giving definitive treatment by suctioning and removing 
the casts by optical forceps [22]. It gives higher illumination 
and visualization and maintains the airway by spontaneous 
ventilation throughout the procedure [28]. Combined suctioning 
and improved visualization by optical forceps are helpful for 
complete removal of the endobronchial casts. Although the 
tenacious consistency and friable nature of the casts is often a 
Figure 1: Chest X-ray (Posteroanterior view) showing radiopaque 
cast in the right endobronchial airway
Figure 2: Endobronchial cast after bronchoscopic removal
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challenge for endoscopic removal, airway clearance is usually 
done adequately by rigid bronchoscopy.
Bronchoalveolar lavage with rigid suctioning is usually better 
than optical forceps for friable casts, whereas firmly adherent 
endobronchial casts are easily removed by optical forceps. This 
cast can be removed by the bronchoscopy forceps. Premedication 
with injection atropine helps to reduce airway secretions and 
prevents from bradycardia in response to airway manipulation 
by rigid bronchoscope [29,30]. The muscle relaxant is used 
for controlled ventilation which helps in easier removal of 
foreign body. Careful intermittent ventilation helpful for proper 
oxygenation and prevent dislodgment of foreign body or cast 
further down in the bronchus [31].
Adjunctive treatment beyond rigid bronchoscopy and 
physiotherapy are usually pharmacological options such as 
corticosteroids, macrolide antibiotics, inhaled tissue plasminogen 
activator, and dornase alfa on the basis of the underlying 
histopathological etiology [32]. In clinical conditions such as 
lymphatic leakage and CHD and surgical interventions such as 
thoracic duct ligation and fenestration of the Fontan circuit would 
prevent cast formation [33]. Recent studies (Benjamin et al.) have 
shown that some patients where underlying comorbidities are not 
fitting with Seear histopathological classification might present 
with challenge for finding appropriate adjunctive treatment 
option [23]. In many cases of PB, rigid bronchoscopy procedure 
completely clears the endobronchial airway and prevents fatal 
airway complications.
PROGNOSIS
PB has a poorer prognosis in patients with underlying cardiac 
defects in comparison to other diseases as the mortality rate is high. 
Children of PB with allergies or asthma have no life-threatening 
events. Patients have a greater mortality rate with Type-II 
(acellular) casts. Deaths in PB with cardiac defects are sudden 
in nature due to widespread and complete airway obstruction. 
This makes the care of the children more difficult and needs 
close follow-up and immediate visit if respiratory symptoms are 
seen [11]. Overall the prognosis is good in PB except in cases 
of CHDs where mortality could be as high as 29% and around 
41% of the patients present with life-threatening situations as 
reported by Uchel et al [11]. As most of the patients with PB have 
an underlying disease, it is often difficult to cure cast formation. 
Majority of the patients require serial bronchoscopic procedure 
because of complete airway obstruction.
CONCLUSION
PB is an uncommon disease seen in the pediatric age group. If 
the pediatric patient presents with persistent cough even after 
adequate and prolonged treatment, a high suspect for this rare 
disease is mandatory. PB may result in complete obstruction of 
the tracheobronchial airway which is a medical emergency which 
needs a multidisciplinary approach for successful diagnosis and 
treatment. All pediatricians and otolaryngologists should give 
special attention for its diagnosis. Endoscopic evidence of PB 
in the tracheobronchial airway is the gold standard diagnostic 
procedure. Bronchoscopy along with bronchial lavage is often 
considered as the treatment of choice.
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